|

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

RECRUITINGN/ASponsored by Dana-Farber Cancer Institute
Actively Recruiting
PhaseN/A
SponsorDana-Farber Cancer Institute
Started2026-09-18
Est. completion2026-12-30
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.

Eligibility

Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria for Participants (Activities 1a, 2a, 3a):

* Age ≥ 21 years
* Current or previous diagnosis of advanced cancer
* Current or previous experience with cancer pain

Exclusion Criteria for Participants (Activities 1a, 2a, 3a):

* Inability to understand, speak, or read English
* Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.

Conditions3

Advanced CancerCancerPain

Locations1 site

Dana Farber Cancer Institute
Andrea Enzinger, MD617-582-7335andrea_enzinger@dfci.harvard.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.